Martinon-Torres F, Wysocki J, Szenborn L, Carmona-Martinez A, et al. A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1). Vaccine 2023;41:3387-3398.
PMID: 37105892